184 related articles for article (PubMed ID: 7735837)
1. Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk.
Wu X; Knudsen B; Feller SM; Zheng J; Sali A; Cowburn D; Hanafusa H; Kuriyan J
Structure; 1995 Feb; 3(2):215-26. PubMed ID: 7735837
[TBL] [Abstract][Full Text] [Related]
2. Four proline-rich sequences of the guanine-nucleotide exchange factor C3G bind with unique specificity to the first Src homology 3 domain of Crk.
Knudsen BS; Feller SM; Hanafusa H
J Biol Chem; 1994 Dec; 269(52):32781-7. PubMed ID: 7806500
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the amino-terminal SH3 domain of CRK and its natural target proteins.
Matsuda M; Ota S; Tanimura R; Nakamura H; Matuoka K; Takenawa T; Nagashima K; Kurata T
J Biol Chem; 1996 Jun; 271(24):14468-72. PubMed ID: 8662907
[TBL] [Abstract][Full Text] [Related]
4. C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins.
Tanaka S; Morishita T; Hashimoto Y; Hattori S; Nakamura S; Shibuya M; Matuoka K; Takenawa T; Kurata T; Nagashima K
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3443-7. PubMed ID: 7512734
[TBL] [Abstract][Full Text] [Related]
5. Proline-rich sequences that bind to Src homology 3 domains with individual specificities.
Alexandropoulos K; Cheng G; Baltimore D
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3110-4. PubMed ID: 7536925
[TBL] [Abstract][Full Text] [Related]
6. Affinity and specificity requirements for the first Src homology 3 domain of the Crk proteins.
Knudsen BS; Zheng J; Feller SM; Mayer JP; Burrell SK; Cowburn D; Hanafusa H
EMBO J; 1995 May; 14(10):2191-8. PubMed ID: 7774577
[TBL] [Abstract][Full Text] [Related]
7. Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions.
Feng S; Chen JK; Yu H; Simon JA; Schreiber SL
Science; 1994 Nov; 266(5188):1241-7. PubMed ID: 7526465
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of the abl-SH3 domain complexed with a designed high-affinity peptide ligand: implications for SH3-ligand interactions.
Pisabarro MT; Serrano L; Wilmanns M
J Mol Biol; 1998 Aug; 281(3):513-21. PubMed ID: 9698566
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the SH3 domain of betaPIX in complex with a high affinity peptide from PAK2.
Hoelz A; Janz JM; Lawrie SD; Corwin B; Lee A; Sakmar TP
J Mol Biol; 2006 Apr; 358(2):509-22. PubMed ID: 16527308
[TBL] [Abstract][Full Text] [Related]
10. The SH3 domain of Crk binds specifically to a conserved proline-rich motif in Eps15 and Eps15R.
Schumacher C; Knudsen BS; Ohuchi T; Di Fiore PP; Glassman RH; Hanafusa H
J Biol Chem; 1995 Jun; 270(25):15341-7. PubMed ID: 7797522
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling.
Arold S; Franken P; Strub MP; Hoh F; Benichou S; Benarous R; Dumas C
Structure; 1997 Oct; 5(10):1361-72. PubMed ID: 9351809
[TBL] [Abstract][Full Text] [Related]
12. The 1.1 A resolution crystal structure of the p130cas SH3 domain and ramifications for ligand selectivity.
Wisniewska M; Bossenmaier B; Georges G; Hesse F; Dangl M; Künkele KP; Ioannidis I; Huber R; Engh RA
J Mol Biol; 2005 Apr; 347(5):1005-14. PubMed ID: 15784259
[TBL] [Abstract][Full Text] [Related]
13. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G.
Posern G; Zheng J; Knudsen BS; Kardinal C; Müller KB; Voss J; Shishido T; Cowburn D; Cheng G; Wang B; Kruh GD; Burrell SK; Jacobson CA; Lenz DM; Zamborelli TJ; Adermann K; Hanafusa H; Feller SM
Oncogene; 1998 Apr; 16(15):1903-12. PubMed ID: 9591773
[TBL] [Abstract][Full Text] [Related]
14. Direct binding of p130(Cas) to the guanine nucleotide exchange factor C3G.
Kirsch KH; Georgescu MM; Hanafusa H
J Biol Chem; 1998 Oct; 273(40):25673-9. PubMed ID: 9748234
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of guanine-nucleotide exchange activity of C3G for Rap1 by the expression of Crk, CrkL, and Grb2.
Ichiba T; Kuraishi Y; Sakai O; Nagata S; Groffen J; Kurata T; Hattori S; Matsuda M
J Biol Chem; 1997 Aug; 272(35):22215-20. PubMed ID: 9268367
[TBL] [Abstract][Full Text] [Related]
16. High-resolution crystal structures of tyrosine kinase SH3 domains complexed with proline-rich peptides.
Musacchio A; Saraste M; Wilmanns M
Nat Struct Biol; 1994 Aug; 1(8):546-51. PubMed ID: 7664083
[TBL] [Abstract][Full Text] [Related]
17. Structure of a regulatory complex involving the Abl SH3 domain, the Crk SH2 domain, and a Crk-derived phosphopeptide.
Donaldson LW; Gish G; Pawson T; Kay LE; Forman-Kay JD
Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14053-8. PubMed ID: 12384576
[TBL] [Abstract][Full Text] [Related]
18. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
Sparks AB; Rider JE; Hoffman NG; Fowlkes DM; Quillam LA; Kay BK
Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1540-4. PubMed ID: 8643668
[TBL] [Abstract][Full Text] [Related]
19. Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains.
Lim WA; Richards FM; Fox RO
Nature; 1994 Nov; 372(6504):375-9. PubMed ID: 7802869
[TBL] [Abstract][Full Text] [Related]
20. The crystal structure of the N-terminal SH3 domain of Grb2.
Guruprasad L; Dhanaraj V; Timm D; Blundell TL; Gout I; Waterfield MD
J Mol Biol; 1995 May; 248(4):856-66. PubMed ID: 7752246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
